# FDA 483 - Adam M. Sun, M.D - February 25, 2022

Source: https://www.keypedia.com/records/483/adam-m-sun-md/ca6f7236-b607-4025-956f-fc3d9c44ad41

> FDA 483 for Adam M. Sun, M.D on February 25, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Adam M. Sun, M.D
- Inspection Date: 2022-02-25
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: Adam M. Sun, M.D. in Rosemead, CA, was cited for significant deficiencies in clinical trial conduct during an FDA inspection. Observations included failures to conduct investigations according to protocol, delayed reporting of adverse events to the sponsor, inadequate investigational drug disposition records, and inaccurate case histories. These issues indicate a lack of adherence to regulatory requirements for clinical investigations.

## Related Officers

- [investigator](https://www.keypedia.com/people/zerita-white/82b19f0c-bd17-4a44-8523-8986f38851a8)

Company: https://www.keypedia.com/companies/adam-m-sun-md/5ec4a2e0-adfb-41d1-8afc-ca26fec073bb

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab